Hypertension in Women: Part I

The basis for the treatment of hypertension in women has evolved in step with the inclusion of women in studies of treatment in hypertension. Recent outcome trials comparing angiotensin‐converting enzyme inhibitors, angiotensin receptor blockers, or calcium antagonists with diuretics and β‐blockers...

Full description

Saved in:
Bibliographic Details
Published inThe journal of clinical hypertension (Greenwich, Conn.) Vol. 10; no. 5; pp. 406 - 410
Main Authors Igho Pemu, Priscilla, Ofili, Elizabeth
Format Journal Article
LanguageEnglish
Published Malden, USA Blackwell Publishing Inc 01.05.2008
Subjects
Antihypertensive Agents - therapeutic use
Blood Pressure - physiology
Female
Global Health
Humans
Hypertension - drug therapy
Hypertension - epidemiology
Hypertension - physiopathology
Morbidity - trends
Prognosis
Online AccessGet full text

Cover

More Information
Summary:The basis for the treatment of hypertension in women has evolved in step with the inclusion of women in studies of treatment in hypertension. Recent outcome trials comparing angiotensin‐converting enzyme inhibitors, angiotensin receptor blockers, or calcium antagonists with diuretics and β‐blockers in older, high‐risk patients have generally shown similar benefits for women and men. The current evidence therefore indicates that sex should not play a role in decisions about whether to treat hypertension or about the choice of agents.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:1524-6175
1751-7176
DOI:10.1111/j.1751-7176.2008.06552.x